Post-doctoral positions available in the CMRI Genome Integrity Group (Cesare Laboratory)

Dr Cesare’s laboratory has postdoctoral positions, fully funded for three years, starting in late 2016 or early 2017.  We are in search of exceptional young scientists, interested in pursuing research on telomeres and genome stability. Opportunities exist in my lab for post-doctoral scientists to investigate:

1)      the interplay between genomic DNA replication stress, or DNA damage, and telomere deprotection

2)      mechanisms of telomere deprotection during ageing and in cancer

3)      telomere biology in mitosis

4)      mitotic chromosome dynamics

5)      post-translational modifications in telomere deprotection signalling

6)      nuclear architecture in the DNA damage response

Ideal candidates will be hard working, independent, and creative in their experimental approach. I also welcome candidates with established excellence in CRISPR/Cas9 mediated gene-editing, quantitative microscopy and/or automated imaging analysis, super-resolution microscopy, proteomics, ChIP-seq and RNA-seq.

Dr Cesare’s is located at the Children’s Medical Research Institute (CMRI) in Sydney, Australia. CMRI is home to the highest concentration of telomere research labs at a single institution worldwide (four groups headed by Professor Roger Reddel, Associate Professors Tracy Bryan and Hilda Pickett, and Dr Cesare).  Researchers at CMRI are supported by core facilities including an internationally unique telomere imaging and analysis facility, and a vector and genome engineering facility to assist with viral vector production and CRISPR/Cas9 gene editing. We also have established collaborations across Sydney to facilitate any additional experimental needs.

Remuneration packages start at $80,000 AUD/annum.

More information on our laboratory is available online (cmri.org.au or cmri.academia.edu/AnthonyCesare) and on twitter (@TheCesareLab).

Interested candidates please contact Dr Cesare’s directly at: tcesare@cmri.org.au

Kindest Regards,

Tony Cesare

Head of the CMRI Genome Integrity Group
Cancer Institute NSW Future Research Leader